Inhibition of BRAF alone is associated with drug-resistance due to paradoxical hyperactivation of MEK, and combined inhibition of BRAF and MEK helps minimize resistance and improve outcomes.246 Treatment with BRAF and MEK inhibitors in combination is associated with an increased risk of HF compared to BRAF inhibitor monotherapy. This evidence concerns the gene BRAF and hydrops fetalis.